Chemokines control mobilization, recruitment, and fate of monocytes in atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 5, 2015, Pages 1050-1055

  Drechsler, Maik ^a,b,c   Duchene, Johan ^a   Soehnlein, Oliver ^a,b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

atherosclerosis; chemokines; monocytes

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR6; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; CXCL2 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

ARTICLE; ATHEROSCLEROSIS; CELL FATE; CELL MIGRATION; DISEASE COURSE; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REMISSION; STEADY STATE; CELL DEATH; CELL MOTION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

ATHEROSCLEROSIS; CELL DEATH; CELL MOVEMENT; CHEMOKINES; HOMEOSTASIS; HUMANS; HYPERCHOLESTEROLEMIA; MONOCYTES; SENSITIVITY AND SPECIFICITY;

EID: 84933054783     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304649     Document Type: Article

References (57)

1. Watanabe T, Hirata M, Yoshikawa Y, Nagafuchi Y, Toyoshima H, Watanabe T, Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab Invest 1985 53 80 90
2. Gown AM, Tsukada T, Ross R, Human atherosclerosis II Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986 125 191 207
3. Ylitalo R, Oksala O, Ylä-Herttuala S, Ylitalo P, Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits. J Lab Clin Med 1994 123 769 776
4. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K, Development of monocytes, macrophages, and dendritic cells. Science 2010 327 656 661. doi: 10.1126/science.1178331
5. Ziegler-Heitbrock L, Ancuta P, Crowe S, Nomenclature of monocytes and dendritic cells in blood. Blood 2010 116 e74 e80. doi: 10.1182/blood-2010-02-258558
6. Soehnlein O, Drechsler M, Döring Y, Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol Med 2013 5 471 481. doi: 10.1002/emmm.201201717
7. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ, Ly-6Chi monocytes dominate hypercholesterolemia-Associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007 117 195 205. doi: 10.1172/JCI29950
8. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z, Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008 117 1649 1657. doi: 10.1161/CIRCULATIONAHA.107.745091
9. Olivares R, Ducimetière P, Claude JR, Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 1993 137 49 53
10. Friedman GD, Klatsky AL, Siegelaub AB, The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974 290 1275 1278. doi: 10.1056/NEJM197406062902302
11. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O, Hyperlipidemia-Triggered neutrophilia promotes early atherosclerosis. Circulation 2010 122 1837 1845. doi: 10.1161/CIRCULATIONAHA.110.961714
12. Serbina NV, Pamer EG, Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006 7 311 317. doi: 10.1038/ni1309
13. Jia T, Serbina NV, Brandl K, Zhong MX, Leiner IM, Charo IF, Pamer EG, Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. J Immunol 2008 180 6846 6853
14. Westerterp M, Gourion-Arsiquaud S, Murphy AJ, Shih A, Cremers S, Levine RL, Tall AR, Yvan-Charvet L, Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 2012 11 195 206. doi: 10.1016/j.stem.2012.04.024
15. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ, Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009 325 612 616. doi: 10.1126/science.1175202
16. Robbins CS, Chudnovskiy A, Rauch PJ, Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 2012 125 364 374. doi: 10.1161/CIRCULATIONAHA.111.061986
17. Broxmeyer HE, Cooper S, Cacalano G, Hague NL, Bailish E, Moore MW, Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue. J Exp Med 1996 184 1825 1832
18. Broxmeyer HE, Sherry B, Cooper S, Ruscetti FW, Williams DE, Arosio P, Kwon BS, Cerami A, Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. J Immunol 1991 147 2586 2594
19. Boring L, Gosling J, Cleary M, Charo IF, Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998 394 894 897. doi: 10.1038/29788
20. Massberg S, Brand K, Grüner S, Page S, Müller E, Müller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M, A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002 196 887 896
21. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K, Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003 9 61 67. doi: 10.1038/nm810
22. Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP, The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012 120 e73 e82. doi: 10.1182/blood-2012-04-416594
23. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ, Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007 117 185 194. doi: 10.1172/JCI28549
24. Bannert N, Craig S, Farzan M, Sogah D, Santo NV, Choe H, Sodroski J, Sialylated O-glycans and sulfated tyrosines in the NH2-Terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines. J Exp Med 2001 194 1661 1673
25. Döring Y, Noels H, Mandl M, Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication. Circ Res 2014 114 976 981. doi: 10.1161/CIRCRESAHA.114.302426
26. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F, Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 2004 94 253 261. doi: 10.1161/01.RES.0000109793.17591.4E
27. Cipriani S, Francisci D, Mencarelli A, Renga B, Schiaroli E, D'Amore C, Baldelli F, Fiorucci S, Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. Circulation 2013 127 2114 2124. doi: 10.1161/CIRCULATIONAHA.113.001278
28. Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C, Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007 27 373 379. doi: 10.1161/01.ATV.0000253886.44609.ae
29. Dutta P, Courties G, Wei Y, Myocardial infarction accelerates atherosclerosis. Nature 2012 487 325 329. doi: 10.1038/nature11260
30. Blanchet X, Cesarek K, Brandt J, Herwald H, Teupser D, Küchenhoff H, Karshovska E, Mause SF, Siess W, Wasmuth H, Soehnlein O, Koenen RR, Weber C, von Hundelshausen P, Inflammatory role and prognostic value of platelet chemokines in acute coronary syndrome. Thromb Haemost 2014 112 1277 1287. doi: 10.1160/TH14-02-0139
31. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C, Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009 15 97 103. doi: 10.1038/nm.1898
32. Boisvert WA, Rose DM, Johnson KA, Fuentes ME, Lira SA, Curtiss LK, Terkeltaub RA, Up-regulated expression of the CXCR2 ligand KC/GRO-Alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol 2006 168 1385 1395
33. Zhou Z, Subramanian P, Sevilmis G, Globke B, Soehnlein O, Karshovska E, Megens R, Heyll K, Chun J, Saulnier-Blache JS, Reinholz M, van Zandvoort M, Weber C, Schober A, Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab 2011 13 592 600. doi: 10.1016/j.cmet.2011.02.016
34. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA, A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 1998 101 353 363. doi: 10.1172/JCI1195
35. Bernhagen J, Krohn R, Lue H, MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007 13 587 596. doi: 10.1038/nm1567
36. Simons D, Grieb G, Hristov M, Pallua N, Weber C, Bernhagen J, Steffens G, Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J Cell Mol Med 2011 15 668 678. doi: 10.1111/j.1582-4934.2010.01041.x
37. Stark K, Eckart A, Haidari S, Tirniceriu A, Lorenz M, von Brühl ML, Gärtner F, Khandoga AG, Legate KR, Pless R, Hepper I, Lauber K, Walzog B, Massberg S, Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs. Nat Immunol 2013 14 41 51. doi: 10.1038/ni.2477
38. Müller I, Schönberger T, Schneider M, Gremlin-1 is an inhibitor of macrophage migration inhibitory factor and attenuates atherosclerotic plaque growth in ApoE-/-Mice. J Biol Chem 2013 288 31635 31645. doi: 10.1074/jbc.M113.477745
39. Wuttge DM, Zhou X, Sheikine Y, Wågsäter D, Stemme V, Hedin U, Stemme S, Hansson GK, Sirsjö A, CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004 24 750 755. doi: 10.1161/01.ATV.0000124102.11472.36
40. Aslanian AM, Charo IF, Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 2006 114 583 590. doi: 10.1161/CIRCULATIONAHA.105.540583
41. Barlic J, Zhu W, Murphy PM, Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion. J Immunol 2009 182 7928 7936. doi: 10.4049/jimmunol.0804112
42. Galkina E, Harry BL, Ludwig A, Liehn EA, Sanders JM, Bruce A, Weber C, Ley K, CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation 2007 116 1801 1811. doi: 10.1161/CIRCULATIONAHA.106.678474
43. Rousselle A, Qadri F, Leukel L, Yilmaz R, Fontaine JF, Sihn G, Bader M, Ahluwalia A, Duchene J, CXCL5 limits macrophage foam cell formation in atherosclerosis. J Clin Invest 2013 123 1343 1347. doi: 10.1172/JCI66580
44. Gleissner CA, Shaked I, Little KM, Ley K, CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol 2010 184 4810 4818. doi: 10.4049/jimmunol.0901368
45. Nassar T, Sachais BS, Akkawi S, Kowalska MA, Bdeir K, Leitersdorf E, Hiss E, Ziporen L, Aviram M, Cines D, Poncz M, Higazi AA, Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 2003 278 6187 6193. doi: 10.1074/jbc.M208894200
46. Robbins CS, Hilgendorf I, Weber GF, Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 2013 19 1166 1172. doi: 10.1038/nm.3258
47. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, Lira SA, Weissman IL, Weber C, Jung S, CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009 113 963 972. doi: 10.1182/blood-2008-07-170787
48. White GE, McNeill E, Channon KM, Greaves DR, Fractalkine promotes human monocyte survival via a reduction in oxidative stress. Arterioscler Thromb Vasc Biol 2014 34 2554 2562. doi: 10.1161/ATVBAHA.114.304717
49. Colin S, Chinetti-Gbaguidi G, Staels B, Macrophage phenotypes in atherosclerosis. Immunol Rev 2014 262 153 166. doi: 10.1111/imr.12218
50. Erbel C, Tyka M, Helmes CM, Akhavanpoor M, Rupp G, Domschke G, Linden F, Wolf A, Doesch A, Lasitschka F, Katus HA, Gleissner CA, CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo. Innate Immun 2015 21 255 265. doi: 10.1177/1753425914526461
51. Gleissner CA, Shaked I, Erbel C, Böckler D, Katus HA, Ley K, CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ Res 2010 106 203 211. doi: 10.1161/CIRCRESAHA.109.199505
52. Trogan E, Feig JE, Dogan S, Rothblat GH, Angeli V, Tacke F, Randolph GJ, Fisher EA, Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc Natl Acad Sci U S A 2006 103 3781 3786. doi: 10.1073/pnas.0511043103
53. Feig JE, Shang Y, Rotllan N, Vengrenyuk Y, Wu C, Shamir R, Torra IP, Fernandez-Hernando C, Fisher EA, Garabedian MJ, Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. PLoS One 2011 6 e28534. doi: 10.1371/journal.pone.0028534
54. van Gils JM, Derby MC, Fernandes LR, The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol 2012 13 136 143. doi: 10.1038/ni.2205
55. Wanschel A, Seibert T, Hewing B, Ramkhelawon B, Ray TD, van Gils JM, Rayner KJ, Feig JE, O'Brien ER, Fisher EA, Moore KJ, Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention. Arterioscler Thromb Vasc Biol 2013 33 886 893. doi: 10.1161/ATVBAHA.112.300941
56. Potteaux S, Gautier EL, Hutchison SB, van Rooijen N, Rader DJ, Thomas MJ, Sorci-Thomas MG, Randolph GJ, Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/-mice during disease regression. J Clin Invest 2011 121 2025 2036. doi: 10.1172/JCI43802
57. Drechsler M, de Jong R, Rossaint J, Viola JR, Leoni G, Wang JM, Grommes J, Hinkel R, Kupatt C, Weber C, Döring Y, Zarbock A, Soehnlein O, Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment. Circ Res 2015 116 827 835